At the HIV Analyst & Investor Event on Tuesday, Gilead Sciences Inc. (NASDAQ:GILD) revealed that it is developing a ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Discover how the breakthrough HepB-CpG vaccine Heplisav-B offers up to 99 protection for people with HIV outperforming older ...

A groundbreaking antipsychotic, a powerful new antibiotic, and a vaccine-like prophylactic for HIV are some of the most ...

In men, most new infections come from sex or injection ... but scientists are still searching for the Holy Grail in HIV–vaccines and cures for everyone. Soon after the discovery of HIV ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, ...

People with HIV often have impaired immunity ... never been vaccinated against hepatitis B. The new analysis included three arms: the HepB-CpG vaccine in three doses, the HepB-alum vaccine in ...

Prioritizing disease prevention naturally requires implementing effective immunization campaigns while also fostering an environment that encourages the development of new vaccine technologies. Behind ...

May 30, 2024 — A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of ... A Trial HIV Vaccine Triggered Elusive and Essential ...

A newer hepatitis B vaccine significantly outperformed an older vaccine in providing protective antibodies for people living with HIV who had failed to respond to previous vaccination, according to a ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, ...